ATEX Valuation

Anterix Inc

Add to Watchlist

Advanced Chart

32.460

-0.090(-0.280%)

Overview
Forecast
Valuation

ATEX Relative Valuation

ATEX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ATEX is overvalued; if below, it's undervalued.

Historical Valuation

Anterix Inc (ATEX) is now in the Overvalued zone, suggesting that its current forward PS ratio of 95.35 is considered Overvalued compared with the five-year average of 229.57. The fair price of Anterix Inc (ATEX) is between 25.50 to 31.09 according to relative valuation methord. Compared to the current price of 32.46 USD , Anterix Inc is Overvalued By 4.40%.

Relative Value

Fair Zone

25.50-31.09

Current Price：32.46

4.40%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

4.20

P/B

Median3y

4.00

Median5y

4.03

-1.10

FCF Yield

Median3y

1.28

Median5y

0.04

Competitors Valuation Multiple

The average P/S ratio for ATEX's competitors is 18.43, providing a benchmark for relative valuation. Anterix Inc Corp (ATEX) exhibits a P/S ratio of 95.35, which is 417.37% above the industry average. Given its robust revenue growth of 23.21%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap